Article
Oncology
Ming-Ying Lu, Ta-Wei Liu, Po-Cheng Liang, Ching- Huang, Yi-Shan Tsai, Yu-Min Ko, Pei-Chien Tsai, Wen-Hsuan Wang, Ching-Chih Lin, Kuan-Yu Chen, Shu-Chi Wang, Yu-Ju Wei, Po-Yao Hsu, Tyng-Yuan Jang, Ming -Yen Hsieh, Chih-Wen Wang, Ming-Lun Yeh, Zu-Yau Lin, Chung-Feng Huang, Jee-Fu Huang, Chia-Yen Dai, Wan-Long Chuang, Ming-Lung Yu
Summary: This study developed a machine learning-based model to predict the risk of hepatocellular carcinoma (HCC) in patients after successful eradication of the hepatitis C virus. The study found that changes in the expression of specific genes were significantly associated with HCC development. This research provides valuable insights for personalized HCC surveillance.
AMERICAN JOURNAL OF CANCER RESEARCH
(2023)
Article
Immunology
Chen-Ta Chi, Chi-Yi Chen, Chien-Wei Su, Po-Yueh Chen, Chi-Jen Chu, Keng-Hsin Lan, I-Cheng Lee, Ming-Chih Hou, Yi-Hsiang Huang
Summary: The study examines the impact of DAAs treatment on HCC patients with CHC in Taiwan, showing high SVR rates within BCLC B HCV-HCC patients and no increased risk of HCC recurrence or progression. For intermediate stage HCC patients, DAAs treatment results in a high percentage maintaining in BCLC B status.
JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION
(2021)
Article
Oncology
Ming-Ying Lu, Ta-Wei Liu, Po-Cheng Liang, Ching- Huang, Yi-Shan Tsai, Pei-Chien Tsai, Yu-Min Ko, Wen-Hsuan Wang, Ching-Chih Lin, Kuan-Yu Chen, Shu-Chi Wang, Yu-Ju Wei, Po-Yao Hsu, Tyng-Yuan Jang, Ming-Yen Hsieh, Chih-Wen Wang, Ming-Lun Yeh, Zu-Yau Lin, Chung-Feng Huang, Jee-Fu Huang, Chia-Yen Dai, Wan-Long Chuang, Ming-Lung Yu
Summary: This study established a machine learning-based HCC model using artificial intelligence to predict the occurrence of HCC by integrating clinical features and genetic biomarkers. The results showed that changes in gene expression before and after treatment were significantly correlated with HCC development. A gene score derived from a decision tree algorithm could accurately identify HCC, and a prediction model combining the gene score and fibrosis-4 index had high accuracy in predicting HCC probability.
AMERICAN JOURNAL OF CANCER RESEARCH
(2023)
Review
Cell Biology
Saleh A. Alqahtani, Massimo Colombo
Summary: Chronic infections with hepatitis B or C virus are common risk factors for hepatocellular carcinoma. Effective antiviral therapies can reduce the risk of developing HCC, but do not eliminate it completely. More strategies are needed to further improve outcomes in preventing HCC in patients with chronic viral hepatitis.
Article
Oncology
Chiara Rocha, Erin H. Doyle, Chip A. Bowman, M-Isabel Fiel, Ashley E. Stueck, Nicolas Goossens, Kian Bichoupan, James F. Crismale, Jasnit Makkar, Sara Lewis, Ponni V. Perumalswami, Thomas D. Schiano, Yujin Hoshida, Myron Schwartz, Andrea D. Branch, Neal Patel
Summary: Successful treatment of hepatitis C reduces liver inflammation and fibrosis, but patients are still at risk of developing hepatocellular carcinoma. Risk factors for post-SVR HCC include non-Caucasian race, smoking, age over 60, low albumin level, elevated AST/ALT ratio, and low platelet count. AFP may be a promising marker for post-SVR HCC risk.
Article
Oncology
Ziqi Ye, Xin Zhang, Yanfang Zhang, Linqing Liu, Zixue Xuan, Ping Huang
Summary: The expression of DDX60L gene is associated with the clinicopathological features of hepatocellular carcinoma patients and may serve as a prognostic marker and therapeutic target.
FRONTIERS IN ONCOLOGY
(2022)
Article
Oncology
Neehar D. Parikh, Neil Mehta, Maarouf A. Hoteit, Ju Dong Yang, Binu John, Andrew M. Moon, Reena J. Salgia, Anjana Pillai, Ihab Kassab, Naba Saeed, Emil Thyssen, Piyush Nathani, Jeffrey McKinney, Wesley Chan, Claire Durkin, Matthew Connor, Manaf Alsudaney, Rajesh Konjeti, Brenda Durand, Nicholas N. Nissen, Hannah P. Kim, Raghavendra Paknikar, Nicole E. Rich, Matthew J. Schipper, Amit G. Singal
Summary: Sustained viral response (SVR) improves survival for patients with hepatitis C (HCV) and hepatocellular carcinoma (HCC) after curative treatment, but the benefit of SVR in patients with active HCC and significant competing risk of mortality is unknown. This study aimed to evaluate the association between SVR and outcomes in patients with active HCC.
Article
Immunology
Ruonan Sun, Jiawei Li, Xianyi Lin, Yidong Yang, Bing Liu, Tianbi Lan, Shuang Xiao, Anyi Deng, Zhinan Yin, Yan Xu, Zheng Xiang, Bin Wu
Summary: This study aimed to explore the changes in peripheral immunity in patients with HBV-related hepatocellular carcinoma (HBV-HCC). The results showed that circulating lymphocytes in HBV-HCC patients exhibited features of immune exhaustion, especially in patients with persistent viral replication and in those with intermediate and advanced HBV-HCC. The combination of CD3(+) T cells and CD8(+)HLADR(+)CD38(+) T cells may serve as a potential diagnostic indicator for HBV-HCC.
FRONTIERS IN IMMUNOLOGY
(2023)
Review
Microbiology
Toofan Datfar, Michael Doulberis, Apostolis Papaefthymiou, Ian N. Hines, Giulia Manzini
Summary: Viral hepatitis, especially hepatitis B and C, are closely associated with hepatocellular carcinoma development. Different genotypes of hepatitis B virus show varied disease progression, and mutations in viral genomes can predict HCC development. HCV infection leads to hepatocellular lipid accumulation associated with oncogenesis.
Article
Gastroenterology & Hepatology
Solomon Owusu Sekyere, Kerstin Port, Katja Deterding, Markus Cornberg, Heiner Wedemeyer
Summary: This study aimed to evaluate the effects of direct-acting antiviral therapy-induced hepatitis C cure on plasmatic markers of systemic inflammation measured before, during and after treatment. Specific soluble immune mediators at elevated concentrations before therapy, such as MCP-3, GDNF, CDCP1, IL-17C, IL-17A, were found to distinguish patients who developed posttreatment hepatocellular carcinoma.
UNITED EUROPEAN GASTROENTEROLOGY JOURNAL
(2021)
Article
Gastroenterology & Hepatology
Takashi Kumada, Hidenori Toyoda, Satoshi Yasuda, Takanori Ito, Kunihiko Tsuji, Shinichi Fujioka, Atsushi Hiraoka, Kazuya Kariyama, Kazuhiro Nouso, Toru Ishikawa, Tsutomu Tamai, Toshifumi Tada, Junko Tanaka
Summary: The risk factors for hepatocellular carcinoma (HCC) development in patients with sustained virological response (SVR) duration of over 10 years remain unclear. The annual incidence rates of HCC development within 10 years and beyond 10 years after SVR were 0.568% and 0.190% respectively. Factors such as male gender, fibrosis-4 (FIB-4) score > 3.25, and alpha-fetoprotein >= 5.0 ng/ml were independently associated with HCC development within 10 years after SVR, while factors such as male gender, presence of diabetes mellitus, and elevated gamma-glutamyl transpeptidase (GGT) were independently associated with HCC development beyond 10 years after SVR.
JOURNAL OF VIRAL HEPATITIS
(2022)
Article
Oncology
Saranya Chidambaranathan Reghupaty, Sadia Kanwal, Rachel G. Mendoza, Eva Davis, Haiwen Li, Zhao Lai, Mikhail G. Dozmorov, Milton Omar Faison, Rafat Ali Siddiqui, Devanand Sarkar
Summary: Hepatocellular carcinoma (HCC) is a common primary liver cancer influenced by chronic liver inflammation and race/ethnicity. Analysis of RNA-sequencing data revealed the activation of an inflammatory pathway in HCC tumors of African-American/Black patients. Ginger extract (GE), known for its anti-inflammatory properties, showed potential efficacy in inhibiting HCC cell growth, particularly in cells from African-American/Black patients. These findings suggest that a holistic diet containing ginger may benefit African-American/Black HCC patients.
Article
Biochemistry & Molecular Biology
Marwa A. Ali, Olfat G. Shaker, Eman M. Ezzat, Hanaa M. Eid, Doaa Y. Ali, Essam A. Hassan, Dalia H. Elsayed, Eman R. Abozaid, Omayma O. Abdelaleem
Summary: This study aimed to investigate whether NBAT-1 and FOXCUT could serve as diagnostic serum biomarkers for HCC. The serum expression levels of NBAT-1 and FOXCUT were measured using quantitative real-time polymerase chain reaction in 165 hepatitis C virus-related HCC Egyptian patients, 180 HCV-infected noncancer patients, and 180 healthy controls. The results showed that NBAT-1 levels were significantly higher in HCC and HCV patients compared to controls, while FOXCUT levels were significantly lower in HCC patients but higher in HCV patients compared to controls. HCV patients had higher levels of NBAT-1 and FOXCUT compared to HCC patients. In addition, a positive correlation was found between NBAT-1 and FOXCUT in both HCC and HCV groups. Multivariate regression analysis indicated that FOXCUT was an independent predictor for HCC among HCV patients.
MOLECULAR CARCINOGENESIS
(2023)
Review
Gastroenterology & Hepatology
Xin Hao, Rong Fan, Hong-Mei Zeng, Jin-Lin Hou
Summary: Hepatocellular carcinoma (HCC) is a major primary liver cancer that poses a global health challenge. Predicting HCC risk in patients with chronic liver disease is an effective strategy for improving early diagnosis and prognosis of HCC. Combining novel technologies and machine learning algorithms could enhance the predictive accuracy of HCC risk score models and integrated early warning and diagnosis systems.
JOURNAL OF CLINICAL AND TRANSLATIONAL HEPATOLOGY
(2023)
Review
Gastroenterology & Hepatology
Lorenza Rimassa, Richard S. Finn, Bruno Sangro
Summary: Single-agent immune checkpoint inhibitors (ICIs) have limited efficacy in advanced hepatocellular carcinoma (HCC) patients, and approximately 30% of patients show intrinsic resistance to ICIs. Therefore, researchers are exploring combination therapies, such as anti-angiogenic agents and other ICIs. Some trials have shown promising results and potential for clinical application. However, there are still many unanswered questions that require further research.
JOURNAL OF HEPATOLOGY
(2023)
Article
Oncology
Takeshi Hatanaka, Satoru Kakizaki, Atsushi Hiraoka, Kazuya Kariyama, Kunihiko Tsuji, Toru Ishikawa, Hidenori Toyoda, Satoshi Yasuda, Atsushi Naganuma, Toshifumi Tada, Koichi Takaguchi, Akemi Tsutsui, Ei Itobayashi, Noritomo Shimada, Hiroshi Shibata, Takaaki Tanaka, Takuya Nagano, Michitaka Imai, Shinichiro Nakamura, Kazuhiro Nouso, Hisashi Kosaka, Masaki Kaibori, Takashi Kumada
Summary: This retrospective study compared the survival of elderly and non-elderly patients with hepatocellular carcinoma (HCC) and found that despite improvement in liver function, survival in elderly patients did not improve. The study suggests that curative treatments should be evaluated and conducted when appropriate for each elderly patient.
Letter
Gastroenterology & Hepatology
Hidenori Toyoda, Kazuya Kariyama, Atsushi Hiraoka
ALIMENTARY PHARMACOLOGY & THERAPEUTICS
(2023)
Article
Gastroenterology & Hepatology
Yuya Seko, Hirokazu Takahashi, Hidenori Toyoda, Hideki Hayashi, Kanji Yamaguchi, Michihiro Iwaki, Masato Yoneda, Taeang Arai, Toshihide Shima, Hideki Fujii, Asahiro Morishita, Kazuhito Kawata, Kengo Tomita, Miwa Kawanaka, Yuichi Yoshida, Tadashi Ikegami, Kazuo Notsumata, Satoshi Oeda, Yoshihiro Kamada, Yoshio Sumida, Hideaki Fukushima, Eiji Miyoshi, Shinichi Aishima, Takeshi Okanoue, Atsushi Nakajima, Yoshito Itoh, Japan Study Grp
Summary: This multicenter cohort study aimed to evaluate the accuracy of the enhanced liver fibrosis (ELF) test for diagnosing hepatic fibrosis in Japanese patients with nonalcoholic fatty liver disease (NAFLD). The results showed that the ELF test is effective in predicting NAFLD-related fibrosis and its diagnostic ability is comparable to other indices, with the combined values of ELF plus other indices being more accurate.
HEPATOLOGY RESEARCH
(2023)
Article
Gastroenterology & Hepatology
Hideki Fujii, Makoto Fujii, Michihiro Iwaki, Hideki Hayashi, Hidenori Toyoda, Satoshi Oeda, Hideyuki Hyogo, Miwa Kawanaka, Asahiro Morishita, Kensuke Munekage, Kazuhito Kawata, Tsubasa Tsutsumi, Koji Sawada, Tatsuji Maeshiro, Hiroshi Tobita, Yuichi Yoshida, Masafumi Naito, Asuka Araki, Shingo Arakaki, Takumi Kawaguchi, Hidenao Noritake, Masafumi Ono, Tsutomu Masaki, Satoshi Yasuda, Eiichi Tomita, Masato Yoneda, Norifumi Kawada, Akihiro Tokushige, Yoshihiro Kamada, Hirokazu Takahashi, Shinichiro Ueda, Shinichi Aishima, Yoshio Sumida, Atsushi Nakajima, Takeshi Okanoue
Summary: This study found that platelet counts at the time of liver biopsy are associated with the development of HCC in patients with NAFLD. Patients with lower platelet counts have a higher risk of developing HCC. Active surveillance is necessary for patients with platelet counts below 192 x 109/L.
HEPATOLOGY RESEARCH
(2023)
Article
Gastroenterology & Hepatology
Hiroshi Ishiba, Yoshio Sumida, Yoshihiro Kamada, Hideki Fujii, Michihiro Iwaki, Hideki Hayashi, Hidenori Toyoda, Satoshi Oeda, Hideyuki Hyogo, Miwa Kawanaka, Asahiro Morishita, Kensuke Munekage, Kazuhito Kawata, Tsubasa Tsutsumi, Koji Sawada, Tatsuji Maeshiro, Hiroshi Tobita, Yuichi Yoshida, Masafumi Naito, Asuka Araki, Shingo Arakaki, Takumi Kawaguchi, Hidenao Noritake, Masafumi Ono, Tsutomu Masaki, Satoshi Yasuda, Eiichi Tomita, Masato Yoneda, Akihiro Tokushige, Hirokazu Takahashi, Shinichiro Ueda, Shinichi Aishima, Atsushi Nakajima, Takeshi Okanoue
Summary: This study aimed to examine the prognostic accuracy of noninvasive tests (NITs) for liver-related mortality (LRM) and events (LREs) in patients with nonalcoholic fatty liver disease (NAFLD). The results showed that NITs can accurately predict LRM and LREs, and can be an alternative method for the prognosis assessment of NAFLD.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
(2023)
Editorial Material
Gastroenterology & Hepatology
Hidenori Toyoda
LIVER INTERNATIONAL
(2023)
Article
Hematology
Hirohito Imada, Tomoyuki Akita, Aya Sugiyama, Junko Tanaka
Summary: The Blood Donation Promotion Study Group of the Ministry of Health, Labor and Welfare in Japan predicted a blood donation rate of 5.7% in 2025. However, the COVID-19 pandemic may affect the blood donation rate in Japan. This study used data from 75.5 million blood donations from 2006 to 2020 to predict age-specific blood donation rates from 2021 to 2035 using an age-period-cohort model.
Article
Gastroenterology & Hepatology
Eiichi Ogawa, Dae Won Jun, Hidenori Toyoda, Yao-Chun Hsu, Eileen L. Yoon, Sang Bong Ahn, Ming-Lun Yeh, Son Do, Huy N. Trinh, Hirokazu Takahashi, Masaru Enomoto, Norifumi Kawada, Satoshi Yasuda, Cheng-Hao Tseng, Keigo Kawashima, Han Ah Lee, Kaori Inoue, Hiroaki Haga, Ai-Thien Do, Mayumi Maeda, Joseph H. Hoang, Ramsey Cheung, Yoshiyuki Ueno, Yuichiro Eguchi, Norihiro Furusyo, Ming-Lung Yu, Yasuhito Tanaka, Mindie H. Nguyen
Summary: The switch from nucleos(t)ide analogues to tenofovir alafenamide resulted in improved viral suppression, increased bone density, and stable renal function in patients with chronic hepatitis B.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS
(2023)
Article
Gastroenterology & Hepatology
Hiroko Setoyama, Nao Nishida, Shintaro Nagashima, Ko Ko, Taiji Yamazoe, Yasuhito Tanaka, Masashi Mizokami, Junko Tanaka, Tatsuya Kanto
Summary: This study aimed to establish a reliable host genome analysis technique for countries with inadequate infrastructure, and found associations between HLA-DPB1 and hepatitis B in the Cambodian population.
HEPATOLOGY RESEARCH
(2023)
Article
Gastroenterology & Hepatology
Takanori Ito, Hikaru Morooka, Hirokazu Takahashi, Hideki Fujii, Michihiro Iwaki, Hideki Hayashi, Hidenori Toyoda, Satoshi Oeda, Hideyuki Hyogo, Miwa Kawanaka, Asahiro Morishita, Kensuke Munekage, Kazuhito Kawata, Tsubasa Tsutsumi, Koji Sawada, Tatsuji Maeshiro, Hiroshi Tobita, Yuichi Yoshida, Masafumi Naito, Asuka Araki, Shingo Arakaki, Takumi Kawaguchi, Hidenao Noritake, Masafumi Ono, Tsutomu Masaki, Satoshi Yasuda, Eiichi Tomita, Masato Yoneda, Akihiro Tokushige, Masatoshi Ishigami, Yoshihiro Kamada, Shinichiro Ueda, Shinichi Aishima, Yoshio Sumida, Atsushi Nakajima, Takeshi Okanoue
Summary: Based on the FIB-4 index and body mass index, our study identified population clusters in NAFLD patients using a clustering approach, which helps assess prognosis. The clustering analysis found that the FIB-4 index is an important predictor of mortality in NAFLD patients regardless of BMI.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
(2023)
Article
Gastroenterology & Hepatology
Tatsuya Minami, Masaya Sato, Hidenori Toyoda, Satoshi Yasuda, Tomoharu Yamada, Takuma Nakatsuka, Kenichiro Enooku, Hayato Nakagawa, Hidetaka Fujinaga, Masashi Izumiya, Yasuo Tanaka, Motoyuki Otsuka, Takamasa Ohki, Masahiro Arai, Yoshinari Asaoka, Atsushi Tanaka, Kiyomi Yasuda, Hideaki Miura, Itsuro Ogata, Toshiro Kamoshida, Kazuaki Inoue, Ryo Nakagomi, Masatoshi Akamatsu, Hiroshi Mitsui, Hajime Fujie, Keiji Ogura, Koji Uchino, Hideo Yoshida, Kazuyuki Hanajiri, Tomonori Wada, Kiyohiko Kurai, Hisato Maekawa, Yuji Kondo, Shuntaro Obi, Takuma Teratani, Naohiko Masaki, Kayo Nagashima, Takashi Ishikawa, Naoya Kato, Hiroshi Yotsuyanagi, Kyoji Moriya, Takashi Kumada, Mitsuhiro Fujishiro, Kazuhiko Koike, Ryosuke Tateishi
Summary: A machine learning model has been developed to predict the risk of hepatocellular carcinoma (HCC) in patients with chronic hepatitis C after achieving a sustained virologic response (SVR). The model showed good discriminative ability in external validation and can generate individualized predictive curves for each patient using an online application.
JOURNAL OF HEPATOLOGY
(2023)
Article
Oncology
Atsushi Hiraoka, Takashi Kumada, Toshifumi Tada, Hidenori Toyoda, Kazuya Kariyama, Takeshi Hatanaka, Satoru Kakizaki, Atsushi Naganuma, Ei Itobayashi, Kunihiko Tsuji, Toru Ishikawa, Hideko Ohama, Fujimasa Tada, Kazuhiro Nouso
Summary: This study developed an AI-based system to predict the prognosis of hepatocellular carcinoma patients at the time of recurrence, aiming to guide treatment selection. The system showed promising results in predicting short- and medium-term survival rates for both initial and recurrent HCC cases.
Article
Oncology
Kazunari Tanaka, Kunihiko Tsuji, Atsushi Hiraoka, Toshifumi Tada, Masashi Hirooka, Kazuya Kariyama, Joji Tani, Masanori Atsukawa, Koichi Takaguchi, Ei Itobayashi, Shinya Fukunishi, Toru Ishikawa, Kazuto Tajiri, Hironori Ochi, Hidenori Toyoda, Chikara Ogawa, Takashi Nishimura, Takeshi Hatanaka, Satoru Kakizaki, Noritomo Shimada, Kazuhito Kawata, Atsushi Naganuma, Hisashi Kosaka, Tomomitsu Matono, Hidekatsu Kuroda, Yutaka Yata, Hideko Ohama, Fujimasa Tada, Kazuhiro Nouso, Asahiro Morishita, Akemi Tsutsui, Takuya Nagano, Norio Itokawa, Tomomi Okubo, Taeang Arai, Keisuke Yokohama, Hiroki Nishikawa, Michitaka Imai, Yohei Koizumi, Shinichiro Nakamura, Hiroko Iijima, Masaki Kaibori, Yoichi Hiasa, Takashi Kumada
Summary: This study aimed to evaluate the ability of a TM score involving AFP, AFP-L3, and DCP to predict the prognosis and therapeutic efficacy in HCC patients treated with Atez/Bev. The results showed that the TM score was useful in predicting the overall survival (OS) and progression-free survival (PFS) in these patients. The mALBI grade was also a good predictor of OS and PFS.
Article
Public, Environmental & Occupational Health
Akemi Kurisu, Aya Sugiyama, Tomoyuki Akita, Ichiro Takumi, Hitoshi Yamamoto, Koji Iida, Junko Tanaka
Summary: This study estimated the prevalence and incidence rates of epilepsy in Japan using nationwide insurance claims data. The results showed that over an 8-year period, a total of 77,312 individuals were diagnosed with epilepsy, resulting in a prevalence rate of 6.0 per 1,000. The incidence rate was 72.1 per 100,000 person-years, with higher rates among females. The highest incidence rates were observed among infants under 12 months and the elderly aged 70-74 years. These findings are important for informing health policies.
JOURNAL OF EPIDEMIOLOGY
(2023)
Article
Radiology, Nuclear Medicine & Medical Imaging
Hideo Ichikawa, Eisuke Yasuda, Takashi Kumada, Kenji Takeshima, Sadanobu Ogawa, Akikazu Tsunekawa, Tatsuya Goto, Koji Nakaya, Tomoyuki Akita, Junko Tanaka
Summary: This study compared the application of ultrasound and magnetic resonance elastography in diagnosing liver fibrosis, and found that the two methods were interchangeable within a clinically acceptable range.